EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NIR-II Nanomedicine Engineered CAR-NK Cells for Precision Navigation and Potentiating Lung Cancer Immunotherapy by Remodeling Tumor Microenvironment

Yeneng Dai, Qihang Ding iD, Ze Chen, Guanda Jiao, Yiqi Yang, Shengyu Fu, Ziyi Yang, Xiaoxi Liu, Kun Qian, Zhen Cheng iD, Dongliang Leng, Qi Zhao

Journal of the American Chemical Society · 18.03.2026 · 148 (10) · 11317-11332

DOI: 10.1021/jacs.6c01128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 06.03.2026. Verfasst von Yeneng Dai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Centre, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR 999078, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Lung Neoplasms, Nanomedicine, Killer Cells, Natural. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade de Macau, Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High Resolution Image Download MS PowerPoint Slide Despite the prominent success against hematologic malignancies in clinical settings, chimeric antigen receptor NK (CAR-NK) cell immunotherapy is still hindered in lung cancer tumors owing to insufficient infiltration and poor immune activation induced by the immunosuppressive tumor microenvironment (TME). Herein, a nanoengineered CAR-NK biohybrid (CK-PSI) was constructed by conjugating nanomedicine (PSI NPs) containing a near-infrared II (NIR-II) polymer and a specific small-molecule inhibitor of Smad3 (SIS3) to the surface of metabolic glycan-engineered CAR-NK cells via a bioorthogonal reaction. Anti-B7H3 CAR modification on cell vectors offers selectively targeted delivery of hitchhiking NIR-II nanomedicine into lung cancer tumors, simultaneously enabling real-time tracking of CAR-NK cells and precise localization of deep-seated tumors through NIR-II fluorescence imaging. NIR-II excitation mild photothermal therapy not only destroys tumor cells by thermal ablation but also promotes the infiltration and penetration of CK-PSI through the rupture of physical barriers within tumor tissues. More importantly, the in situ release of the Smad3 inhibitor further reduces extracellular matrix (ECM) deposition through TGF-β signaling pathway blockade in the TME, thereby boosting the infiltration and immune activation of CAR-NK cells. The bioorthogonal nanohybrid with NIR-II phototheranostic triggered cell localization and immunomodulatory capabilities provides a new paradigm for potentiating the infiltration and immune activation efficiency of CAR-NK cells against solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentLung NeoplasmsNanomedicineKiller Cells, NaturalImmunotherapyReceptors, Chimeric AntigenHumansAnimalsInfrared RaysSmad3 ProteinMice

Substanzen

Receptors, Chimeric AntigenSmad3 Protein

Autor:innen und Institutionen

  • Cancer Centre, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR 999078, China.
  • MoE Frontiers Science Center for Precision Oncology, University of Macau, Taipa, Macau SAR 999078, China.
  • Department of Chemistry, Korea University, Seoul 02841, Korea.
  • State Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.

ORCID-Profile: Qihang Ding, Zhen Cheng

Förderung

  • Universidade de Macau
  • Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia
  • Natural Science Foundation of Guangdong Province
  • Chinese Academy of Sciences
  • National Basic Research Program of China (973 Program)

Zitieren

APA

Dai, Y., Ding, Q., Chen, Z., Jiao, G., Yang, Y., Fu, S., Yang, Z., Liu, X., Qian, K., Cheng, Z., Leng, D., & Zhao, Q. (2026). NIR-II Nanomedicine Engineered CAR-NK Cells for Precision Navigation and Potentiating Lung Cancer Immunotherapy by Remodeling Tumor Microenvironment. Journal of the American Chemical Society, 148(10), 11317-11332. https://doi.org/10.1021/jacs.6c01128

Vancouver

Dai Y, Ding Q, Chen Z, Jiao G, Yang Y, Fu S, et al. NIR-II Nanomedicine Engineered CAR-NK Cells for Precision Navigation and Potentiating Lung Cancer Immunotherapy by Remodeling Tumor Microenvironment. Journal of the American Chemical Society. 2026;148(10):11317-11332. doi:10.1021/jacs.6c01128

BibTeX
@article{Dai2026,
  author = {Dai, Yeneng and Ding, Qihang and Chen, Ze and Jiao, Guanda and Yang, Yiqi and Fu, Shengyu and Yang, Ziyi and Liu, Xiaoxi and Qian, Kun and Cheng, Zhen and Leng, Dongliang and Zhao, Qi},
  title = {NIR-II Nanomedicine Engineered CAR-NK Cells for Precision Navigation and Potentiating Lung Cancer Immunotherapy by Remodeling Tumor Microenvironment},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {10},
  pages = {11317--11332},
  doi = {10.1021/jacs.6c01128}
}
Kostenlos starten →